GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Viet Nam Pharmaceutical Corp - JSC (HSTC:DVN) » Definitions » Capex-to-Operating-Income

Viet Nam Pharmaceutical - JSC (HSTC:DVN) Capex-to-Operating-Income : 0.06 (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Viet Nam Pharmaceutical - JSC Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Viet Nam Pharmaceutical - JSC's Capital Expenditure for the three months ended in Sep. 2024 was ₫-2,089.89 Mil. Its Operating Income for the three months ended in Sep. 2024 was ₫38,010.89 Mil.

Hence, Viet Nam Pharmaceutical - JSC's Capex-to-Operating-Income for the three months ended in Sep. 2024 was 0.06.


Viet Nam Pharmaceutical - JSC Capex-to-Operating-Income Historical Data

The historical data trend for Viet Nam Pharmaceutical - JSC's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viet Nam Pharmaceutical - JSC Capex-to-Operating-Income Chart

Viet Nam Pharmaceutical - JSC Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
0.66 0.27 0.10 0.57 0.05

Viet Nam Pharmaceutical - JSC Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.07 0.01 0.07 0.06

Competitive Comparison of Viet Nam Pharmaceutical - JSC's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Viet Nam Pharmaceutical - JSC's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viet Nam Pharmaceutical - JSC's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Viet Nam Pharmaceutical - JSC's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Viet Nam Pharmaceutical - JSC's Capex-to-Operating-Income falls into.


;
;

Viet Nam Pharmaceutical - JSC Capex-to-Operating-Income Calculation

Viet Nam Pharmaceutical - JSC's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-8743.563) / 164391.682
=0.05

Viet Nam Pharmaceutical - JSC's Capex-to-Operating-Income for the quarter that ended in Sep. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-2089.894) / 38010.888
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Viet Nam Pharmaceutical - JSC  (HSTC:DVN) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Viet Nam Pharmaceutical - JSC Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Viet Nam Pharmaceutical - JSC's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Viet Nam Pharmaceutical - JSC Business Description

Traded in Other Exchanges
N/A
Address
12 Ngo Tat To, Van Mieu Ward, Dong Da District, Hanoi, VNM
Viet Nam Pharmaceutical Corp - JSC is engaged in the manufacturing of drugs. The company provides testing services for drugs and medicinal ingredients.